BE study in China (for China) [Regulatives / Guidelines]

posted by Shuanghe  – Spain, 2020-06-05 10:56 (713 d 09:28 ago) – Posting: # 21499
Views: 812

Hi John,

» Does anyone know if there is a min sample size requirement for a pivotal (submission) BE study for regulatory submission in China? In US I believe it's n=12 (unless changed), not sure about China.

In the old guidance 18 to 24 subjects were mentioned so I guess that many people considered 18 as minimum number.

There is no minimum size requirement by the new guidance. It only mentions that statistical power should be ensured by the sample size. See link of guidances in that post.

All the best,
Shuanghe

Complete thread:

UA Flag
Activity
 Admin contact
22,085 posts in 4,629 threads, 1,566 registered users;
online 14 (0 registered, 14 guests [including 14 identified bots]).
Forum time: Thursday 20:24 CEST (Europe/Vienna)

That which is not controversial
is of no particular interest.    Johann Wolfgang von Goethe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5